$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
PARP抑制剂对晚期前列腺癌的适应症
2025-10-19 11:44:20
Check Details
联合免疫疗法给晚期前列腺癌患者带来益处
2025-10-19 11:44:20
Check Details
FDA授予EPI-7386治疗mCRPC的快速审核资格
2025-10-19 11:44:20
Check Details
奥拉帕尼显著提高mCRPC亚组的总生存期
2025-10-19 11:44:20
Check Details
新型BiTE免疫肿瘤药物治疗mCRPC的早期疗效观察
2025-10-19 11:44:20
Check Details
奥拉帕尼获批用于治疗转移性去势抵抗性前列腺癌
2025-10-19 11:44:20
Check Details
恩杂鲁胺多少钱
2025-10-19 11:44:20
Check Details
恩杂鲁胺效果怎么样
2025-10-19 11:44:20
Check Details
恩杂鲁胺说明书
2025-10-19 11:44:20
Check Details
恩杂鲁胺的图片
2025-10-19 11:44:20
Check Details
恩杂鲁胺有效果吗
2025-10-19 11:44:20
Check Details
国内恩杂鲁胺多少钱一瓶
2025-10-19 11:44:20
Check Details
1
2
...
1472
1473
1474
1475
1476
1477
1478
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
2
Cemiplimab Storage and Handling Guide
3
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
4
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
5
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
6
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
7
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
8
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
9
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
10
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
11
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
12
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview